Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.

Chen SJ, Wang YL, Fan HC, Lo WT, Wang CC, Sytwu HK.

Clin Dev Immunol. 2012;2012:970789. doi: 10.1155/2012/970789. Epub 2011 Dec 6. Review.

2.

Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.

Rostami A, Ciric B.

J Neurol Sci. 2013 Oct 15;333(1-2):76-87. doi: 10.1016/j.jns.2013.03.002. Epub 2013 Apr 8. Review.

3.

The critical role of antigen-presentation-induced cytokine crosstalk in the central nervous system in multiple sclerosis and experimental autoimmune encephalomyelitis.

Sosa RA, Forsthuber TG.

J Interferon Cytokine Res. 2011 Oct;31(10):753-68. doi: 10.1089/jir.2011.0052. Epub 2011 Sep 15. Review.

4.

IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.

Arbelaez CA, Glatigny S, Duhen R, Eberl G, Oukka M, Bettelli E.

J Immunol. 2015 Sep 1;195(5):1974-83. doi: 10.4049/jimmunol.1403135. Epub 2015 Jul 29.

5.

T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.

Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH.

Clin Exp Immunol. 2010 Oct;162(1):1-11. doi: 10.1111/j.1365-2249.2010.04143.x. Review.

6.

Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.

Aharoni R.

J Autoimmun. 2014 Nov;54:81-92. doi: 10.1016/j.jaut.2014.05.005. Epub 2014 Jun 14. Review.

PMID:
24934599
7.

Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.

Xiao J, Liu W, Chen Y, Deng W.

J Neuroinflammation. 2015 Jun 12;12:117. doi: 10.1186/s12974-015-0338-0.

8.

Restrained Th17 response and myeloid cell infiltration into the central nervous system by human decidua-derived mesenchymal stem cells during experimental autoimmune encephalomyelitis.

Bravo B, Gallego MI, Flores AI, Bornstein R, Puente-Bedia A, Hernández J, de la Torre P, García-Zaragoza E, Perez-Tavarez R, Grande J, Ballester A, Ballester S.

Stem Cell Res Ther. 2016 Mar 17;7:43. doi: 10.1186/s13287-016-0304-5.

9.

IL-17 and related cytokines involved in the pathology and immunotherapy of multiple sclerosis: Current and future developments.

Luchtman DW, Ellwardt E, Larochelle C, Zipp F.

Cytokine Growth Factor Rev. 2014 Aug;25(4):403-13. doi: 10.1016/j.cytogfr.2014.07.013. Epub 2014 Jul 29. Review.

PMID:
25153998
10.
11.
12.

Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Pierson E, Simmons SB, Castelli L, Goverman JM.

Immunol Rev. 2012 Jul;248(1):205-15. doi: 10.1111/j.1600-065X.2012.01126.x. Review.

13.

Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.

Murphy AC, Lalor SJ, Lynch MA, Mills KH.

Brain Behav Immun. 2010 May;24(4):641-51. doi: 10.1016/j.bbi.2010.01.014. Epub 2010 Feb 6.

PMID:
20138983
14.

Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.

Jadidi-Niaragh F, Mirshafiey A.

Scand J Immunol. 2011 Jul;74(1):1-13. doi: 10.1111/j.1365-3083.2011.02536.x. Review.

15.

Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.

Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.

Tohoku J Exp Med. 2007 Dec;213(4):329-39.

17.

MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis.

Zhang J, Cheng Y, Cui W, Li M, Li B, Guo L.

J Neuroimmunol. 2014 Jan 15;266(1-2):56-63. doi: 10.1016/j.jneuroim.2013.09.019. Epub 2013 Oct 8.

PMID:
24332164
18.

Deleterious versus protective autoimmunity in multiple sclerosis.

Kostic M, Stojanovic I, Marjanovic G, Zivkovic N, Cvetanovic A.

Cell Immunol. 2015 Aug;296(2):122-32. doi: 10.1016/j.cellimm.2015.04.006. Epub 2015 Apr 28. Review.

PMID:
25944389
19.

Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.

Álvarez-Sánchez N, Cruz-Chamorro I, López-González A, Utrilla JC, Fernández-Santos JM, Martínez-López A, Lardone PJ, Guerrero JM, Carrillo-Vico A.

Brain Behav Immun. 2015 Nov;50:101-14. doi: 10.1016/j.bbi.2015.06.021. Epub 2015 Jun 27.

PMID:
26130320
20.

Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.

Kebir H, Ifergan I, Alvarez JI, Bernard M, Poirier J, Arbour N, Duquette P, Prat A.

Ann Neurol. 2009 Sep;66(3):390-402. doi: 10.1002/ana.21748.

PMID:
19810097

Supplemental Content

Support Center